| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Duvivier Raphael | Chief Financial Officer | C/O KRISPY KREME, INC., 2116 HAWKINS STREET, SUITE 101, CHARLOTTE | /s/ Christine McDevitt, Attorney-in-fact | 02 Feb 2026 | 0001980019 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DNUT | Common Stock | Award | $0 | +1,382 | +0.25% | $0.000000 | 560,183 | 29 Jan 2026 | Direct | F1 |
| transaction | DNUT | Common Stock | Tax liability | $2,054 | -650 | -0.12% | $3.16 | 559,533 | 29 Jan 2026 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | Consists of shares of common stock received in connection with the achievement of performance criteria tied to previously awarded performance-based restricted stock units ("PSUs"). |
| F2 | Consists of shares surrendered to cover tax withholding for the vesting of PSUs. |
| F3 | Direct: 144,634; unvested RSUs: 414,899. |